Drug repurposing and adverse event prediction using high-throughput literature analysis.

Area of Science:

• Biomedical Informatics
• Pharmacology
• Drug Discovery

Background:

• Traditional drug development faces rising costs and a scarcity of new chemical entities.
• Drug repurposing offers a cost-effective and time-efficient alternative by utilizing existing drugs.
• Existing drug knowledge can be leveraged for predicting adverse events of known or novel drugs.

Purpose of the Study:

• To review literature-based approaches for drug repurposing.
• To explore methods for predicting adverse drug events using biomedical literature.
• To highlight the value of analyzing indirect relationships within biomedical data.

Main Methods:

• Literature analysis to identify indirect relationships among genes, pathways, and diseases.
• Network-based approaches to uncover molecular mechanisms of diseases and drug effects.
• In silico analysis of drug mechanisms of action compared to adverse event mechanisms.

Main Results:

• Biomedical literature analysis can reveal novel drug indications.
• Network analysis aids in understanding drug effects and benefit/risk profiles.
• This approach facilitates the prediction of potential adverse drug events.

Conclusions:

• Literature-driven drug repurposing and adverse event prediction are valuable strategies.
• Analyzing complex biomedical networks enhances understanding of drug actions and safety.
• In silico findings require validation through experimental and clinical studies.